Kennedy’s New Vaccine Advisers Helped Lawyers Raise Doubts About Their Safety

Desperate to break free from opioid addiction, thousands of Americans are traveling to Mexico for an unorthodox and potentially dangerous treatment involving ibogaine—a powerful psychedelic banned in the U.S. While some hail it as a miracle cure for addiction, the drug carries serious risks, including heart complications and even death. This underground medical tourism highlights both the gaps in U.S. addiction care and the extreme measures people are willing to take when traditional treatments fail.

Editor’s Note: This isn’t just a story about a fringe treatment—it’s a symptom of how broken addiction care is in the U.S. When people feel they have no other options, they’ll gamble on unproven, risky solutions. The fact that ibogaine is banned here but sought abroad raises tough questions: Should the U.S. reconsider its stance on alternative therapies, or is the real issue the lack of accessible, effective treatments at home? Either way, it’s a stark reminder of how deep the opioid crisis cuts.

Health regulators have given the green light to lenacapavir, a groundbreaking new drug designed to prevent H.I.V. Unlike daily pills, this one is administered via injection just twice a year—a major leap forward in convenience and accessibility for at-risk populations. It’s being hailed as a potential game-changer in the fight against the virus.

Editor’s Note: H.I.V. prevention has long relied on daily medication, which can be hard to stick to for some people. A twice-yearly shot like lenacapavir could dramatically simplify prevention efforts, especially in communities with limited healthcare access. This isn’t just another drug approval—it’s a shift in how we approach stopping H.I.V. before it starts.

The Trump administration's travel restrictions are causing headaches for U.S. hospitals that rely on foreign doctors. Visa delays and appointment freezes are keeping international medical graduates—many of whom were set to start work in weeks—from filling critical roles, like those at Brooklyn’s Brookdale Hospital.

Editor’s Note: Hospitals already stretched thin are now scrambling to cover gaps left by doctors who can’t get into the country. This isn’t just bureaucratic red tape—it directly affects patient care in communities that depend on these professionals. When policies clash with practical needs, real people feel the consequences.

A new study in JAMA tracked teenagers over several years and found a troubling connection: those who showed signs of screen addiction—like compulsive gaming or social media use—were more likely to exhibit suicidal thoughts or behaviors. The research didn’t just look at screen time but focused on addictive patterns, suggesting it’s not just about how much they’re online, but how unhealthy their relationship with screens becomes.

Editor’s Note: This isn’t just another "screens are bad" headline—it’s a deeper dive into how digital habits can spiral into something far more dangerous. For parents and policymakers, it’s a wake-up call to take screen addiction seriously, not just as a distraction but as a potential risk factor for mental health crises. The study adds weight to growing concerns about how tech impacts young minds, especially when use turns compulsive.

A new study reveals that around 70,000 years ago, early humans in Africa began pushing into harsher, more extreme environments—think deserts, mountains, and dense forests—before eventually spreading across the globe. This adaptability might have been the key to our species' survival and dominance.